Dear Participants We cordially invite you to the 10th KoNECT-MOHW-MFDS International Conference (2024 KIC)

On behalf of the Organizing Committee as well as the Program Committee, we are pleased to invite you to the 2024 KIC, co-hosted by Ministry of Health and Welfare and Ministry of Food and Drug Safety.

KIC has been holding the International Convention every year for invigorating and growing the Korea Clinical Trials and Operations. This years also, we are pleased to announce the 10th KIC will be held on October 29-31, 2024 at Dragon City, Seoul.
Through various programs of KIC 2024 including Recruitment Information Session, Exhibition, and Conference, exchange the newest clinical trials and bio technology as well as get the business opportunity with various international academics, professionals, and CEOs of the global clinical trials and bio-tech of healthcare field.

In our unparalleled conference focused on clinical trials and new drug development in Asia, we are dedicated to ensuring exceptional lecture and presentation quality. Over the course of this three-day program, attendees will gain valuable insights into current trends and future considerations in clinical trials in Korea.

Our comprehensive agenda encompasses a diverse range of sessions, including lectures, talk shows, and more, addressing innovative technologies and approaches in drug development. Topics covered include new drug development cases, regulatory updates concerning FDA IND, emerging therapeutics, and data-driven methodologies.
Notably, sessions on advanced regenerative medicine, bio-pharmaceuticals, and AI-driven drug development will facilitate deep discussions on advancements in medicine and clinical trials. Additionally, specific topics such as oncology, obesity, and Alzheimer's disease will be explored, alongside practical considerations related to operations and quality control essential for conducting successful clinical trials.

We wish to extend our heartfelt gratitude and utmost appreciation to the esteemed members of the Conference Program Committee for their invaluable cooperation and contributions towards enhancing the influence and quality of the conference program. Additionally, we would like to express our profound gratitude to MOHW and MFDS for their unwavering dedication to the mission of public health through their close collaboration and steadfast promotion of the field of clinical trials in Korea.

With genuine sincerity, we hope that your experience at the 2024 KIC will be truly meaningful and rewarding, and that all participants will derive immense satisfaction and enjoyment from their participation in the 10th KoNECT International Conference.